Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia
Open Access
- 15 September 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 12 (05), 599-614
- https://doi.org/10.1017/s1461145708009371
Abstract
Recent advances in the neurobiology of cannabinoids have renewed interest in the association between cannabis and schizophrenia. Our studies showed tKeywords
This publication has 103 references indexed in Scilit:
- Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to SchizophreniaBiological Psychiatry, 2008
- Modelling prefrontal cortex deficits in schizophrenia: implications for treatmentBritish Journal of Pharmacology, 2008
- Why endocannabinoids are not all alikeNature Neuroscience, 2008
- CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamusEuropean Journal of Neuroscience, 2007
- The neuropsychological correlates of cannabis use in schizophrenia: Lifetime abuse/dependence, frequency of use, and recency of useSchizophrenia Research, 2007
- Molecular Composition of the Endocannabinoid System at Glutamatergic SynapsesJournal of Neuroscience, 2006
- Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidoneCurrent Medical Research and Opinion, 2003
- Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousalMedical Hypotheses, 2000
- Sex Steroid Influence on Cannabinoid CB1 Receptor mRNA and Endocannabinoid Levels in the Anterior Pituitary GlandBiochemical and Biophysical Research Communications, 2000
- Regional cerebral blood flow in catatonic schizophreniaPsychiatry Research: Neuroimaging, 1993